Imprimis Pharmaceuticals
- Pharmaceutical Preparations
- Nashville, Tennessee
Compensation history
Top executives at Imprimis Pharmaceuticals received an average of $1M per person in annual compensation from 2007 to 2022.
By year
Executives
We found seven executives who work or worked at Imprimis Pharmaceuticals.
Mark Baum
Imprimis Pharmaceuticals
Chief Executive Officer
Andrew Boll
Imprimis Pharmaceuticals
Chief Financial Officer
John Saharek
Imprimis Pharmaceuticals
Chief Commercial Officer and President, ImprimisRx
Joachim Schupp
Imprimis Pharmaceuticals
Chief Medical Officer
Balbir Brar
Imprimis Pharmaceuticals
Former President
Juliet Singh
Imprimis Pharmaceuticals
Chief Executive Officer
John Lomoro
Imprimis Pharmaceuticals
Chief Financial Officer
News
Imprimis Pharmaceuticals CEO Mark Baum's 2022 pay falls 84% to $1.2M
April 28, 2023
Imprimis Pharmaceuticals CEO Mark Baum's 2021 pay jumps 195% to $7.3M
April 26, 2022
Imprimis Pharmaceuticals CEO Mark Baum's 2020 pay jumps 80% to $2.5M
April 23, 2021
Imprimis Pharmaceuticals CEO Mark Baum's 2019 pay jumps 30% to $1.4M
April 24, 2020
Imprimis Pharmaceuticals CEO Mark Baum's 2018 pay rises 16% to $1.1M
April 25, 2019
About Imprimis Pharmaceuticals
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 102 Woodmont Blvd, Suite 610, Nashville, Tennessee 37215
- 615.733.4731
- December 31
- Former names
- Imprimis Pharmaceuticals, Inc.
- TRANSDEL PHARMACEUTICALS INC
- Bywater Resources, Inc